首页 | 本学科首页   官方微博 | 高级检索  
     

小汤山医院680例SARS患者药物利用分析
引用本文:王睿,周筱青,董军,魏荣,曹秀堂,周亚春,王瑾,郭代红,陈騉,周践,王洁松,朱秀美,梁蓓蓓,徐艳萍,周先志,李幼平,孙鑫,熊鹰. 小汤山医院680例SARS患者药物利用分析[J]. 中国循证医学杂志, 2004, 4(7): 474-481
作者姓名:王睿  周筱青  董军  魏荣  曹秀堂  周亚春  王瑾  郭代红  陈騉  周践  王洁松  朱秀美  梁蓓蓓  徐艳萍  周先志  李幼平  孙鑫  熊鹰
作者单位:1. 解放军总医院,北京,100853
2. 解放军小汤山医院,北京,100000
3. 四川大学华西医院中国循证医学中心,成都,610041
基金项目:国家高技术研究发展计划(863计划)
摘    要:目的调查分析小汤山医院680例临床确诊SARS患者治疗期间的药物利用情况. 方法采用HIS系统回顾性分析小汤山医院临床确诊的680例SARS患者的病案及用药记录,分别运用计算机病例分型模型(A、B、C、D型)和临床分型模型(普通型、重症型)分组,统一采用合理用药指标:限定成人日剂量(defined daily dose, DDD)、药物利用指数(drug utilization index, DUI)、用药例次数、医嘱数及人均药费、日均药费等,评价各组间的差异. 结果 680例SARS患者共计应用17大类359种药物,应用病例数最多的是抗菌药物.应用经费最多的是糖皮质激素和大输液类药物.DDDs排序最高的为免疫调节剂和维生素药物.应用总天数最多的是大输液和维生素类药物.药费最高的是甲基强的松龙注射剂.C型、D型和重症型SARS患者的年龄、死亡率、用药品种、用药频次及经费均显著高于A型和普通型SARS患者. 结论按WHO推荐的合理用药指标DUI=1标准,359种药物中DUI小于、等于和大于1的比例分别为37%、30%和33%.抗病毒药用量不足,激素类用量过大.计算机病例分型客观真实、速度快、易标化,具有推广潜质.

关 键 词:严重急性呼吸综合征  药物利用
文章编号:1672-2531(2004)07-0474-08
修稿时间:2004-05-27

Utilization Analysis of Drug Efficacy of the 680 Cases of SARS Patients in Xiao Tang Shan Hospital of PLA
WANG Rui,ZHOU Xiao-qing,DONG Jun,WEI Rong,CAO Xiu-tang,Z HOU Ya-chun,WANG Jin,GUO Dai-hong,CHEN Kun,ZHOU Jian,WANG Jie-song,ZHU Xiu-mei,LIANG Bei-bei,XU Yan-ping,ZHOU Xian-zh i,LI You-ping,SUN Xin,XIONG Ying. . Chinese PLA General Hospital,Beijing ,China, .Xiao Tang Shan Hospital o f PLA,Beijing ,China, .West China Medical School,Sichuan University,C hengdu ,China. Utilization Analysis of Drug Efficacy of the 680 Cases of SARS Patients in Xiao Tang Shan Hospital of PLA[J]. Chinese Journal of Evidence-based Medicine, 2004, 4(7): 474-481
Authors:WANG Rui  ZHOU Xiao-qing  DONG Jun  WEI Rong  CAO Xiu-tang  Z HOU Ya-chun  WANG Jin  GUO Dai-hong  CHEN Kun  ZHOU Jian  WANG Jie-song  ZHU Xiu-mei  LIANG Bei-bei  XU Yan-ping  ZHOU Xian-zh i  LI You-ping  SUN Xin  XIONG Ying. . Chinese PLA General Hospital  Beijing   China   .Xiao Tang Shan Hospital o f PLA  Beijing   China   .West China Medical School  Sichuan University  C hengdu   China
Affiliation:WANG Rui1,ZHOU Xiao-qing1,DONG Jun1,WEI Rong2,CAO Xiu-tang1,Z HOU Ya-chun2,WANG Jin1,GUO Dai-hong1,CHEN Kun1,ZHOU Jian1,WANG Jie-song2,ZHU Xiu-mei2,LIANG Bei-bei1,XU Yan-ping1,ZHOU Xian-zh i2,LI You-ping3,SUN Xin3,XIONG Ying3. 1. Chinese PLA General Hospital,Beijing 100853,China, 2.Xiao Tang Shan Hospital o f PLA,Beijing 100000,China, 3.West China Medical School,Sichuan University,C hengdu 610041,China
Abstract:Objective To study the medication usage in patients with severe acute respirato r y syndrome (SARS). MethodsThe information o f the medications of 680 patients with SARS in Xiao Tang Shan Hospital was collec ted by HIS system and classified by using computer model on the basis of disease factor. The usage time and cases, and cost of these medications were calculated . The defined daily dose (DDD) and drug utilization index (DUI) were analyzed. ResultsA number of 359 drugs in 17 categories w ere applied to 680 patients with SARS. Most cases used antibacterial agents, the DDDs of immunomodulator and vitamins were the highest, the usage duration of vi tamins and infusion fluids were the longest among 17 kinds of the drugs. The cos t of methylpredni-solone injection was the highest. The mortality rate , kinds o f drugs and frequency of drugs were JP3 higher in type C, type D and serious SARS patients than that of type A and common SARS patients.Conclusi ons Many kinds of medications have been prescribed to SA R S patients. The dosages of these medication are very high, JP especially gluc ocorticoids, immuneomodulator and nutrient agents. The computer model on the bas is of disease factor is probably valid, rapid and easy to standardize.
Keywords:ST5"  B3 Severe acute respireatory syndrome,Medication usage
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号